Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C E Haas

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Drug Intelligence & Clinical Pharmacy|November 1, 1985
Second-generation cephalosporinsC E Haas, J A Paladino
Le Poumon Et Le Coeur|January 1, 1977
[Intrapulmonary solitary round opacities. Diagnosis and therapy]C E Haas, F X Lebas, P Choubrac
Pharmacotherapy|October 17, 2001
Effects of metronidazole on hepatic CYP3A4 activityC E Haas, D C Kaufman, R C DiCenzo
American Journal of Hospital Pharmacy|July 1, 1986
Effect of a preprinted chart note on appropriate cefazolin prescribingC E Haas, J A Paladino, J R Dibona
American Journal of Hospital Pharmacy|May 1, 1992
Effect of using a standard polyvinyl chloride intravenous infusion set on patient response to nitroglycerinC E Haas, D R Nowak, W A Mabb
Archives of Surgery (Chicago, Ill. : 1960)|October 28, 1998
Antibiotic susceptibility in the surgical intensive care unit compared with the hospital-wide antibiogramD Kaufman, C E Haas, R Edinger, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1990
In vitro selection of resistant Helicobacter pyloriC E Haas, D E Nix, J J Schentag
American Journal of Hospital Pharmacy|February 15, 1994
Clinical response to intravenous nitroglycerin infused through polyethylene or polyvinyl chloride tubingJ L Altavela, C E Haas, D R Nowak, et al.
Clinical Pharmacology and Therapeutics|April 1, 1994
Lithium pharmacokinetics in the obeseR A Reiss, C E Haas, S D Karki, et al.
Pharmacotherapy|June 10, 1998
Bioavailability of phenytoin acid and phenytoin sodium with enteral feedingsK K Doak, C E Haas, K J Dunnigan, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Drug Intelligence & Clinical Pharmacy|November 1, 1985
Second-generation cephalosporinsC E Haas, J A Paladino
Le Poumon Et Le Coeur|January 1, 1977
[Intrapulmonary solitary round opacities. Diagnosis and therapy]C E Haas, F X Lebas, P Choubrac
Pharmacotherapy|October 17, 2001
Effects of metronidazole on hepatic CYP3A4 activityC E Haas, D C Kaufman, R C DiCenzo
American Journal of Hospital Pharmacy|July 1, 1986
Effect of a preprinted chart note on appropriate cefazolin prescribingC E Haas, J A Paladino, J R Dibona
American Journal of Hospital Pharmacy|May 1, 1992
Effect of using a standard polyvinyl chloride intravenous infusion set on patient response to nitroglycerinC E Haas, D R Nowak, W A Mabb
Archives of Surgery (Chicago, Ill. : 1960)|October 28, 1998
Antibiotic susceptibility in the surgical intensive care unit compared with the hospital-wide antibiogramD Kaufman, C E Haas, R Edinger, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1990
In vitro selection of resistant Helicobacter pyloriC E Haas, D E Nix, J J Schentag
American Journal of Hospital Pharmacy|February 15, 1994
Clinical response to intravenous nitroglycerin infused through polyethylene or polyvinyl chloride tubingJ L Altavela, C E Haas, D R Nowak, et al.
Clinical Pharmacology and Therapeutics|April 1, 1994
Lithium pharmacokinetics in the obeseR A Reiss, C E Haas, S D Karki, et al.
Pharmacotherapy|June 10, 1998
Bioavailability of phenytoin acid and phenytoin sodium with enteral feedingsK K Doak, C E Haas, K J Dunnigan, et al.
Pageof 1